ArticleTherapeutic advances in hematology2024

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study.

Julie Kanter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.